Page last updated: 2024-10-19

melatonin and Ovarian Cysts

melatonin has been researched along with Ovarian Cysts in 1 studies

Ovarian Cysts: General term for CYSTS and cystic diseases of the OVARY.

Research Excerpts

ExcerptRelevanceReference
"In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels."7.69Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997)
"In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels."3.69Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartsch, C1
Bartsch, H1
Karenovics, A1
Franz, H1
Peiker, G1
Mecke, D1

Other Studies

1 other study available for melatonin and Ovarian Cysts

ArticleYear
Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
    Journal of pineal research, 1997, Volume: 23, Issue:2

    Topics: Breast Neoplasms; Female; Fibroadenoma; Fibrocystic Breast Disease; Humans; Leiomyoma; Melatonin; Mi

1997